By binding to TXNIP promoter in E-box -containing region, c-Myc competes with MondoA and represses TXNIP expression in TNBC, indeed a c-Mychigh/TXNIPlow signature correlates with poor OS specifically in this subclass of breast cancer [36]. The gene discussed is MYC; the disease is breast carcinoma.